TriOptimize IX: Real-world improvement in COPD symptoms and lung function by extrafine single-inhaler triple therapy (efSITT)
F. Trinkmann (Heidelberg, Germany), S. Bahari Javan (Hamburg, Germany), C. Criée (Bovenden, Germany), V. Bogoevska (Hamburg, Germany), C. Gessner (Leipzig, Germany)
Source: International Congress 2022 – COPD clinical studies and exacerbations
Session: COPD clinical studies and exacerbations
Session type: Thematic Poster
Number: 3618
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Trinkmann (Heidelberg, Germany), S. Bahari Javan (Hamburg, Germany), C. Criée (Bovenden, Germany), V. Bogoevska (Hamburg, Germany), C. Gessner (Leipzig, Germany). TriOptimize IX: Real-world improvement in COPD symptoms and lung function by extrafine single-inhaler triple therapy (efSITT). 3618
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|